Product Description
| Cat Number | IG-080 |
|---|---|
| Category | Peptide |
| Pack Size | 1 mg |
| Description | Inactivates β1 integrins |
| Modification | None |
| Purity | >95% by hplc |
| Biomarker Target | Integrin receptors |
| Sequence Three Letter Code | H-Thr-Glu-Ala-Thr-Ile-Thr-Gly-Leu-Glu-Pro-Gly-Thr-Glu-Tyr-Thr-Ile-Tyr-Val-Ile-Ala-Leu-OH |
| Molecular Formula | C103H163N21O35 |
| Sl Sequence | TEATITGLEPGTEYTIYVIAL |
| Solubility | Soluble in water |
| Appearance | Freeze dried solid |
| Storage | Store dry, frozen and in the dark |
| References |
Fukai et al (1997) Identification of the anti-adhesive site buried within the heparin-binding domain of fibronectin. J Biochem. 121(2) 189 PMID: 9089388Fujita (2020) Involvement of Integrin-Activating Peptides Derived from Tenascin-C in Cancer Aggression and New Anticancer Strategy Using the Fibronectin-Derived Integrin-Inactivating Peptide. Molecules 25(14) 3239 PMID: 32708610Fujita et al (2021) Biofunctional Peptide FNIII14: Therapeutic Potential. Encyclopedia 1(2) 350 https://doi.org/10.3390/encyclopedia1020029 Related areas All peptides >All integrin receptor modulators >All cancer research areas > |
| Note | The product is for research use only |
Share Item: